Overactive Bladder Treatment Market Research Report by Therapy Type (Anticholinergic, BOTO, Darifenacin, Fesoterodine, and Mirabegron), by Disease Type (Idiopathic Bladder Overactivity and Neurogenic Bladder Overactivity) - Global Forecast to 2025 - Cumulative Impact of COVID-19 Market Statistics: The report provides...
‘Candidemia – Epidemiology Forecast—2030’ report delivers an in-depth understanding of the Candidemia, historical and forecasted epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Candidemia Disease Understanding Candidemia is defined as the presence of Candida...
Consumer health is expected to see higher current value growth in 2020 than was seen the previous year. One of the factors driving growth in this year is COVID-19. As news about the virus emerged and the country went into lockdown, consumers began panic-buying in March, stockpiling certain consumer health products, such as analgesics, cough,...
Overall, consumer health is expected to perform well, due to increased demand as a result of COVID-19, with most areas product areas expected to register double-digit current value growth. Though 2020 current value growth is not expected to be as high as in 2019, a lot of the growth over the review period was driven by inflation rather than...
The Asia Pacific gastrointestinal drugs market is expected to reach US$ 13,618.35 million by 2027 from US$ 8,868.44 million in 2019; it is expected to grow at a CAGR of 5.6% from 2020 to 2027. Rising prevalence of gastrointestinal (GI) diseases and increase in development of biologics are expected to boost the growth of the market. However,...
The South and Central America gastrointestinal drugs market is expected to reach US$ 5,632.72 million by 2027 from US$ 4,160.28 million in 2019; it is expected to grow at a CAGR of 4.0% from 2020 to 2027. Rising prevalence of gastrointestinal (GI) diseases and increase in development of biologics are expected to boost the growth of the market....
Market Introduction Eye supplements are nutritional products which care recommended to maintain eye health and good vision.The eye health supplements prominently comprises vitamin A, lutein & Zeaxanthin, omega 3 fatty acids, gamma-linoleic acid, and others. These nutritional supplements helps to sustain eye function, reduce the development...
The gastrointestinal drugs market was valued at US$ 49,043.38 million in 2019 and is projected to reach US$ 71,300.28 million by 2027; it is expected to grow at a CAGR of 4.9% from 2020 to 2027. The growth of the gastrointestinal drugs market is mainly attributed to factors such as rise in prevalence of gastrointestinal (GI) diseasesand...
Overall consumer health sales increased in Italy in 2020, with concerns over COVID-19 fuelling interest in products that help to boost the immune system. As news about the virus emerged in the country, consumers began panic-buying at the beginning of March, stockpiling certain consumer health products, such as analgesics, cough, cold and allergy...
The first cases of COVID-19 in Belarus were recorded on 27 February 2020 and, in June 2020, Belarus continued to record nearly 800 cases of COVID-19 daily. Stockpiling occurred in mid-March 2020, with COVID-19 driving demand for analgesics, cough, cold and allergy (hay fever) remedies, vitamins and dietary supplements. No quarantine took place...